PEG-Benzaldehyde-Hydrazone-Lipid Based PEG-Sheddable pH-Sensitive Liposomes: Abilities for Endosomal Escape and Long Circulation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PEG-Benzaldehyde-Hydrazone-Lipid Based PEG-Sheddable pH-Sensitive Liposomes: Abilities for Endosomal Escape and Long Circulation
Authors
Keywords
dual pH-sensitive liposomes, endosome escape, hydrazone, PEG detachment, tumor
Journal
PHARMACEUTICAL RESEARCH
Volume 35, Issue 8, Pages -
Publisher
Springer Nature
Online
2018-06-01
DOI
10.1007/s11095-018-2429-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- pH-Sensitive PEGylated liposomes for delivery of an acidic dinitrobenzamide mustard prodrug: Pathways of internalization, cellular trafficking and cytotoxicity to cancer cells
- (2017) Mimi M. Yang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
- (2016) Manju Kanamala et al. BIOMATERIALS
- Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells
- (2016) Hongtao Xu et al. PHARMACEUTICAL RESEARCH
- High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer
- (2015) Li Zhang et al. ACS Applied Materials & Interfaces
- New Developments in Liposomal Drug Delivery
- (2015) Bhushan S. Pattni et al. CHEMICAL REVIEWS
- Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation
- (2015) Wenli Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug
- (2015) Hongtao Xu et al. PHARMACEUTICAL RESEARCH
- Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery
- (2014) Jie Tang et al. JOURNAL OF DRUG TARGETING
- Development of High-Content Gemcitabine PEGylated Liposomes and Their Cytotoxicity on Drug-Resistant Pancreatic Tumour Cells
- (2014) Hongtao Xu et al. PHARMACEUTICAL RESEARCH
- The Polyethyleneglycol Dilemma: Advantage and Disadvantage of PEGylation of Liposomes for Systemic Genes and Nucleic Acids Delivery to Tumors
- (2013) Hiroto Hatakeyama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Liposome-like nanostructures for drug delivery
- (2013) Weiwei Gao et al. Journal of Materials Chemistry B
- Cancer nanomedicines: So many papers and so few drugs!
- (2012) Vincent J. Venditto et al. ADVANCED DRUG DELIVERY REVIEWS
- Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs
- (2012) Gina Song et al. JOURNAL OF LIPOSOME RESEARCH
- Near-infrared light-sensitive micelles for enhanced intracellular drug delivery
- (2012) Gong-Yan Liu et al. JOURNAL OF MATERIALS CHEMISTRY
- Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon
- (2011) Daquan Chen et al. International Journal of Nanomedicine
- Fusogenic activity of PEGylated pH-sensitive liposomes
- (2011) Željka Vanić et al. JOURNAL OF LIPOSOME RESEARCH
- pH-Sensitive mPEG-Hz-Cholesterol Conjugates as a Liposome Delivery System
- (2010) Daquan Chen et al. JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
- Effect of the Lipid Chain Melting Transition on the Stability of DSPE-PEG(2000) Micelles
- (2009) Mark Kastantin et al. LANGMUIR
- Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions
- (2009) Roland Andersson et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
- (2008) M. P. Kim et al. CLINICAL CANCER RESEARCH
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
- (2008) James J. Farrell et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation